v2.4.0.6
Intangible Assets
12 Months Ended
Dec. 30, 2011
Goodwill and Intangible Assets [Abstract]  
INTANGIBLE ASSETS

6. INTANGIBLE ASSETS

 Amortizing intangible assets are comprised of the following (in thousands):
              
 AtDecember 30, 2011 Gross Carrying Amount  Accumulated Amortization  Foreign Currency Translation  Net Carrying Amount
 Purchased technology and patents$ 97,324 $ (54,054) $ 842 $ 44,112
 Customer lists  66,388   (14,009)   1,807   54,186
 Other  5,174   (4,019)   805   1,960
 Total amortizing intangible assets$ 168,886 $ (72,082) $ 3,454 $ 100,258
              
 AtDecember 31, 2010           
 Purchased technology and patents$ 83,023 $ (48,187) $ 1,212 $ 36,048
 Customer lists  46,818   (10,577)   2,119   38,360
 Other  3,519   (2,862)   49   706
 Total amortizing intangible assets$ 133,360 $ (61,626) $ 3,380 $ 75,114

 Aggregate intangible asset amortization expense is comprised of the following (in thousands):
            
    Year Ended
    December 30, December 31, January 1,
    2011 2010 2010
 Cost of sales $ 6,163 $ 5,897 $ 6,331
 Selling, general and administrative expenses   3,926   3,765   3,729
 Research, development and engineering costs   367   -   -
 Total intangible asset amortization expense $ 10,456 $ 9,662 $ 10,060

 Estimated future intangible asset amortization expense based upon the current carrying value is as follows (in thousands):
  Estimated
  Amortization
  Expense
 2012$ 14,225
 2013  13,384
 2014  13,533
 2015  12,334
 2016  10,123
 Thereafter  36,659
 Total estimated amortization expense$ 100,258

During 2011, the Company made various asset purchases of technology and patents totaling $6.3 million, which is being amortized over a weighted average period of approximately 11 years. In connection with these purchases, the Company recorded a $3.0 million contingent liability, which will only be paid if certain sales targets for products that utilize that technology are achieved. This contingent liability is currently classified in Other Long-Term Liabilities.

 

As a result of the successful rebranding of the Company, during the fourth quarter of 2009, the Company wrote-down its non-Greatbatch trademarks and tradenames by $15.9 million. This charge was recorded based upon the Company's decision to discontinue use of the associated tradenames and determination that there were no market participants willing to purchase the previously acquired tradenames. In addition to the above, the Company incurred expense of $0.7 million in 2009 related to its rebranding initiative, which includes additional advertising costs, and is included in SG&A. As of December 30, 2011 and December 31, 2010, the Company had a $20.3 million indefinite-lived intangible asset recorded relating to its Greatbatch tradename.

 The change in goodwill during 2011 is as follows (in thousands):
           
    Greatbatch Medical  Electrochem  Total
 AtDecember 31, 2010$ 297,508 $ 9,943 $ 307,451
 Goodwill acquired  -   31,478   31,478
 Foreign currency translation  (276)  0   (276)
 AtDecember 30, 2011$ 297,232 $ 41,421 $ 338,653

As of December 30, 2011, no accumulated impairment loss has been recognized for the goodwill allocated to the Company's Greatbatch Medical or Electrochem segments.